Chemoinformaics analysis of 17alpha-Estradiol
| Molecular Weight | 272.388 | nRot | 0 |
| Heavy Atom Molecular Weight | 248.196 | nRig | 20 |
| Exact Molecular Weight | 272.178 | nRing | 4 |
| Solubility: LogS | -4.368 | nHRing | 0 |
| Solubility: LogP | 4.043 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 3 |
| Atoms Count | 44 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 1 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 18 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
| nHA | 2 | APOL | 47.667 |
| nHD | 2 | BPOL | 24.077 |
| QED | 0.757 |
| Synth | 3.585 |
| Natural Product Likeliness | 2.239 |
| NR-PPAR-gamma | 0.006 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.006 |
| Pgp-sub | 0.997 |
| HIA | 0.008 |
| CACO-2 | -4.596 |
| MDCK | 0.000019 |
| BBB | 0.356 |
| PPB | 0.949102 |
| VDSS | 1.506 |
| FU | 0.0341133 |
| CYP1A2-inh | 0.772 |
| CYP1A2-sub | 0.828 |
| CYP2c19-inh | 0.392 |
| CYP2c19-sub | 0.817 |
| CYP2c9-inh | 0.274 |
| CYP2c9-sub | 0.947 |
| CYP2d6-inh | 0.184 |
| CYP2d6-sub | 0.885 |
| CYP3a4-inh | 0.268 |
| CYP3a4-sub | 0.545 |
| CL | 15.889 |
| T12 | 0.36 |
| hERG | 0.622 |
| Ames | 0.025 |
| ROA | 0.562 |
| SkinSen | 0.95 |
| Carcinogencity | 0.335 |
| EI | 0.238 |
| Respiratory | 0.957 |
| NR-Aromatase | 0.391 |
| Antiviral | No |
| Prediction | 0.733836 |